Published in Proc Natl Acad Sci U S A on March 21, 2005
The neuronal organization of the retina. Neuron (2012) 3.13
Anatomical profiling of G protein-coupled receptor expression. Cell (2008) 2.88
Metabotropic glutamate receptors: from the workbench to the bedside. Neuropharmacology (2010) 2.31
TRPM1 is required for the depolarizing light response in retinal ON-bipolar cells. Proc Natl Acad Sci U S A (2009) 2.27
TRPM1 is a component of the retinal ON bipolar cell transduction channel in the mGluR6 cascade. Proc Natl Acad Sci U S A (2009) 2.20
Differential gene expression of TRPM1, the potential cause of congenital stationary night blindness and coat spotting patterns (LP) in the Appaloosa horse (Equus caballus). Genetics (2008) 2.15
TRPM1 is mutated in patients with autosomal-recessive complete congenital stationary night blindness. Am J Hum Genet (2009) 1.93
Mutations in TRPM1 are a common cause of complete congenital stationary night blindness. Am J Hum Genet (2009) 1.92
The genetics of normal and defective color vision. Vision Res (2010) 1.85
Mutations in CABP4, the gene encoding the Ca2+-binding protein 4, cause autosomal recessive night blindness. Am J Hum Genet (2006) 1.77
On and off domains of geniculate afferents in cat primary visual cortex. Nat Neurosci (2007) 1.71
Recessive mutations of the gene TRPM1 abrogate ON bipolar cell function and cause complete congenital stationary night blindness in humans. Am J Hum Genet (2009) 1.68
TRPM1 mutations are associated with the complete form of congenital stationary night blindness. Mol Vis (2010) 1.37
Allelic variance between GRM6 mutants, Grm6nob3 and Grm6nob4 results in differences in retinal ganglion cell visual responses. J Physiol (2008) 1.36
GPR179 is required for depolarizing bipolar cell function and is mutated in autosomal-recessive complete congenital stationary night blindness. Am J Hum Genet (2012) 1.33
Retinal remodeling. Jpn J Ophthalmol (2012) 1.32
Generation, identification and functional characterization of the nob4 mutation of Grm6 in the mouse. Vis Neurosci (2007) 1.27
Whole-exome sequencing identifies mutations in GPR179 leading to autosomal-recessive complete congenital stationary night blindness. Am J Hum Genet (2012) 1.25
Whole-exome sequencing identifies LRIT3 mutations as a cause of autosomal-recessive complete congenital stationary night blindness. Am J Hum Genet (2012) 1.18
Naturally occurring animal models with outer retina phenotypes. Vision Res (2009) 1.14
Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction. PLoS One (2011) 1.12
Preferential binding of allosteric modulators to active and inactive conformational states of metabotropic glutamate receptors. BMC Bioinformatics (2008) 1.06
Postreceptoral contributions to the light-adapted ERG of mice lacking b-waves. Exp Eye Res (2008) 1.06
Depolarizing bipolar cell dysfunction due to a Trpm1 point mutation. J Neurophysiol (2012) 1.05
A mutation in SLC24A1 implicated in autosomal-recessive congenital stationary night blindness. Am J Hum Genet (2010) 1.05
Faster thalamocortical processing for dark than light visual targets. J Neurosci (2011) 1.03
GNAT1 associated with autosomal recessive congenital stationary night blindness. Invest Ophthalmol Vis Sci (2012) 1.03
Mutations in NYX of individuals with high myopia, but without night blindness. Mol Vis (2007) 1.03
Assessing retinal structure in complete congenital stationary night blindness and Oguchi disease. Am J Ophthalmol (2012) 1.00
A null mutation in CABP4 causes Leber's congenital amaurosis-like phenotype. Mol Vis (2010) 0.98
Adeno-associated virus serotype-9 efficiently transduces the retinal outer plexiform layer. Mol Vis (2009) 0.97
Mouse b-wave mutants. Doc Ophthalmol (2014) 0.97
Retinal remodeling in human retinitis pigmentosa. Exp Eye Res (2016) 0.95
Temporal ChIP-on-Chip of RNA-Polymerase-II to detect novel gene activation events during photoreceptor maturation. Mol Vis (2010) 0.93
Congenital stationary night blindness associated with mutations in GRM6 encoding glutamate receptor MGluR6. Br J Ophthalmol (2006) 0.91
Lrit3 deficient mouse (nob6): a novel model of complete congenital stationary night blindness (cCSNB). PLoS One (2014) 0.89
On- and off-response ERGs elicited by sawtooth stimuli in normal subjects and glaucoma patients. Doc Ophthalmol (2012) 0.86
Sequence variations of GRM6 in patients with high myopia. Mol Vis (2009) 0.86
Molecular profiling of complete congenital stationary night blindness: a pilot study on an Indian cohort. Mol Vis (2014) 0.85
Negative electroretinograms in the pediatric and adult population. Doc Ophthalmol (2012) 0.84
Neurobiological hypothesis of color appearance and hue perception. J Opt Soc Am A Opt Image Sci Vis (2014) 0.84
Intravitreal delivery of a novel AAV vector targets ON bipolar cells and restores visual function in a mouse model of complete congenital stationary night blindness. Hum Mol Genet (2015) 0.84
ON pathway mutations increase susceptibility to form-deprivation myopia. Exp Eye Res (2015) 0.84
Biallelic Mutations in GNB3 Cause a Unique Form of Autosomal-Recessive Congenital Stationary Night Blindness. Am J Hum Genet (2016) 0.83
Curing color blindness--mice and nonhuman primates. Cold Spring Harb Perspect Med (2014) 0.83
Rod-driven OFF pathway responses in the distal retina: dark-adapted flicker electroretinogram in mouse. PLoS One (2012) 0.82
Voriconazole, an antifungal triazol that causes visual side effects, is an inhibitor of TRPM1 and TRPM3 channels. Invest Ophthalmol Vis Sci (2015) 0.82
An extended 15 Hz ERG protocol (2): data of normal subjects and patients with achromatopsia, CSNB1, and CSNB2. Doc Ophthalmol (2011) 0.82
Dysfunction of transmission in the inner retina: incidence and clinical causes of negative electroretinogram. Graefes Arch Clin Exp Ophthalmol (2006) 0.82
Interacting linear and nonlinear characteristics produce population coding asymmetries between ON and OFF cells in the retina. J Neurosci (2013) 0.82
Novel expression patterns of metabotropic glutamate receptor 6 in the zebrafish nervous system. PLoS One (2012) 0.81
SIRT6 is required for normal retinal function. PLoS One (2014) 0.81
Allosteric Modulation of G Protein Coupled Receptors by Cytoplasmic, Transmembrane and Extracellular Ligands. Pharmaceuticals (Basel) (2010) 0.81
"mGlu Receptors in the Retina" - WIREs Membrane Transport and Signaling. Wiley Interdiscip Rev Membr Transp Signal (2012) 0.81
Assessment of night vision problems in patients with congenital stationary night blindness. PLoS One (2013) 0.80
How Azobenzene Photoswitches Restore Visual Responses to the Blind Retina. Neuron (2016) 0.80
Degeneration of retinal on bipolar cells induced by serum including autoantibody against TRPM1 in mouse model of paraneoplastic retinopathy. PLoS One (2013) 0.80
Asymmetrical growth of the photopic hill during the light adaptation effect. Doc Ophthalmol (2010) 0.79
Retinal dystrophies, genomic applications in diagnosis and prospects for therapy. Transl Pediatr (2015) 0.79
Estimating ON and OFF contributions to the photopic hill: normative data and clinical applications. Doc Ophthalmol (2014) 0.79
Mutations in GRM6 identified in consanguineous Pakistani families with congenital stationary night blindness. Mol Vis (2015) 0.78
Circuitry to explain how the relative number of L and M cones shapes color experience. J Vis (2016) 0.78
Photopic ON- and OFF-responses in complete type of congenital stationary night blindness in relation to stimulus intensity. Doc Ophthalmol (2007) 0.78
Gradient of deficit in cone responses in the incomplete form of congenital stationary night blindness revealed by multifocal electroretinography. Doc Ophthalmol (2007) 0.78
Full-field electroretinogram response to increment and decrement stimuli. Doc Ophthalmol (2014) 0.77
Spatial distributions of on- and off-responses determined with the multifocal ERG. Doc Ophthalmol (2010) 0.77
Visually impaired children: "coming to better terms". Doc Ophthalmol (2009) 0.77
Amyloid Precursor-Like Protein 2 deletion-induced retinal synaptopathy related to congenital stationary night blindness: structural, functional and molecular characteristics. Mol Brain (2016) 0.76
A Naturally Occurring Canine Model of Autosomal Recessive Congenital Stationary Night Blindness. PLoS One (2015) 0.76
Identification of a new mutant allele, Grm6(nob7), for complete congenital stationary night blindness. Vis Neurosci (2015) 0.76
Sensitivity and kinetics of signal transmission at the first visual synapse differentially impact visually-guided behavior. Elife (2015) 0.76
Ultrastructural localization of GPR179 and the impact of mutant forms on retinal function in CSNB1 patients and a mouse model. Invest Ophthalmol Vis Sci (2013) 0.75
Effect of Age and Glaucoma on the Detection of Darks and Lights. Invest Ophthalmol Vis Sci (2015) 0.75
Association of ZNF644, GRM6, and CTNND2 genes with high myopia in the Han Chinese population: Jiangsu Eye Study. Eye (Lond) (2016) 0.75
Psychophysical measures of visual function and everyday perceptual experience in a case of congenital stationary night blindness. Clin Ophthalmol (2016) 0.75
Photoreceptor and postreceptor responses in congenital stationary night blindness. Invest Ophthalmol Vis Sci (2013) 0.75
G protein signaling in the retina and beyond: the Cogan lecture. Invest Ophthalmol Vis Sci (2014) 0.75
Novel TRPM1 mutations in two Chinese families with early-onset high myopia, with or without complete congenital stationary night blindness. Int J Ophthalmol (2016) 0.75
Possible roles of glutamate transporter EAAT5 in mouse cone depolarizing bipolar cell light responses. Vision Res (2014) 0.75
The morphology of human rod ERGs obtained by silent substitution stimulation. Doc Ophthalmol (2017) 0.75
An asymmetric outer retinal response to drifting sawtooth gratings. J Neurophysiol (2016) 0.75
Long-Term Clinical Course in a Patient with Complete Congenital Stationary Night Blindness. Case Rep Ophthalmol (2017) 0.75
A missense mutation in Grm6 reduces but does not eliminate mGluR6 expression or rod depolarizing bipolar cell function. J Neurophysiol (2017) 0.75
Human flicker electroretinography using different temporal modulations at mesopic and photopic luminance levels. Doc Ophthalmol (2014) 0.75
Congenital stationary night blindness with hypoplastic discs, negative electroretinogram and thinning of the inner nuclear layer. Graefes Arch Clin Exp Ophthalmol (2016) 0.75
Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature (2000) 6.58
The metabotropic glutamate receptors: structure and functions. Neuropharmacology (1995) 5.11
2-amino-4-phosphonobutyric acid: a new pharmacological tool for retina research. Science (1981) 4.63
Signal transmission along retinal rods and the origin of the electroretinographic a-wave. Nature (1969) 4.61
Congenital stationary night blindness with negative electroretinogram. A new classification. Arch Ophthalmol (1986) 3.90
Functional architecture of the mammalian retina. Physiol Rev (1991) 3.57
A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet (1995) 3.18
[Analysis of the human electroretinogram]. Ophthalmologica (1952) 2.92
Specific deficit of the ON response in visual transmission by targeted disruption of the mGluR6 gene. Cell (1995) 2.81
Molecular characterization of a novel retinal metabotropic glutamate receptor mGluR6 with a high agonist selectivity for L-2-amino-4-phosphonobutyrate. J Biol Chem (1993) 2.80
The eclectroretinogram: its components and their origins. Vision Res (1968) 2.78
Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness. Nat Genet (2000) 2.70
Loss-of-function mutations in a calcium-channel alpha1-subunit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness. Nat Genet (1998) 2.56
An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness. Nat Genet (1998) 2.48
Push-pull model of the primate photopic electroretinogram: a role for hyperpolarizing neurons in shaping the b-wave. Vis Neurosci (1994) 2.33
Ocular findings in patients with autosomal dominant retinitis pigmentosa and a rhodopsin gene defect (Pro-23-His). Arch Ophthalmol (1991) 2.26
Photovoltage of rods and cones in the macaque retina. Science (1995) 2.25
Gap junctions between photoreceptor cells in the vertebrate retina. Proc Natl Acad Sci U S A (1973) 2.19
Defects in the rhodopsin kinase gene in the Oguchi form of stationary night blindness. Nat Genet (1997) 2.19
B-wave of the electroretinogram. A reflection of ON bipolar cell activity. J Gen Physiol (1989) 2.16
Functions of the ON and OFF channels of the visual system. Nature (1986) 2.14
A novel signaling pathway from rod photoreceptors to ganglion cells in mammalian retina. Neuron (1998) 2.13
The complete form of X-linked congenital stationary night blindness is caused by mutations in a gene encoding a leucine-rich repeat protein. Nat Genet (2000) 2.08
Effect of magnesium on horizontal cell activity in the skate retina. Nature (1973) 2.01
Heterozygous missense mutation in the rhodopsin gene as a cause of congenital stationary night blindness. Nat Genet (1993) 1.93
Normal values for the Pelli-Robson contrast sensitivity test. J Cataract Refract Surg (2001) 1.91
A proximal retinal component in the primate photopic ERG a-wave. Invest Ophthalmol Vis Sci (1994) 1.85
Cat cones have rod input: a comparison of the response properties of cones and horizontal cell bodies in the retina of the cat. J Comp Neurol (1977) 1.84
Missense mutation in the gene encoding the alpha subunit of rod transducin in the Nougaret form of congenital stationary night blindness. Nat Genet (1996) 1.68
Photopic ON- and OFF-pathway abnormalities in retinal dystrophies. Trans Am Ophthalmol Soc (1993) 1.63
Microcircuitry of the dark-adapted cat retina: functional architecture of the rod-cone network. J Neurosci (1986) 1.61
On- and off-responses in photopic electroretinogram in complete and incomplete types of congenital stationary night blindness. Jpn J Ophthalmol (1987) 1.53
An alternative pathway for signal flow from rod photoreceptors to ganglion cells in mammalian retina. Proc Natl Acad Sci U S A (1995) 1.53
Night blindness revisited: from man to molecules. Proctor lecture. Invest Ophthalmol Vis Sci (1982) 1.32
Impairment of pupillary responses and optokinetic nystagmus in the mGluR6-deficient mouse. Neuropharmacology (1997) 1.24
Characterization of an extended glutamate receptor of the on bipolar neuron in the vertebrate retina. J Neurosci (1985) 1.22
Primate Retinal Signaling Pathways: Suppressing ON-Pathway Activity in Monkey With Glutamate Analogues Mimics Human CSNB1-NYX Genetic Night Blindness. J Neurophysiol (2004) 1.18
Rod and cone dysfunction in carriers of X-linked retinitis pigmentosa. Ophthalmology (1988) 1.13
Direct synaptic connections between rods and OFF cone bipolar cells in the rabbit retina. J Comp Neurol (2004) 1.12
Narrow-band filtering for monitoring low-amplitude cone electroretinograms in retinitis pigmentosa. Am J Ophthalmol (1988) 1.11
Structure of the metabotropic glutamate receptor. Curr Opin Neurobiol (2003) 1.09
[Establishment of the concept of new clinical entities--complete and incomplete form of congenital stationary night blindness]. Nippon Ganka Gakkai Zasshi (2002) 1.09
Retinal bipolar cell input mechanisms in giant danio. II. Patch-clamp analysis of on bipolar cells. J Neurophysiol (2004) 1.07
NYX (nyctalopin on chromosome X), the gene mutated in congenital stationary night blindness, encodes a cell surface protein. Invest Ophthalmol Vis Sci (2003) 1.06
Slow and fast rod ERG pathways in patients with X-linked complete stationary night blindness carrying mutations in the NYX gene. Invest Ophthalmol Vis Sci (2001) 1.05
Mutations in the human Ca(2+)-sensing-receptor gene that cause familial hypocalciuric hypercalcemia. Am J Hum Genet (1995) 1.03
On-off interaction in the human electroretinogram. J Opt Soc Am (1961) 0.97
A distinctive form of congenital stationary night blindness with cone ON-pathway dysfunction. Ophthalmology (2002) 0.96
Mutated alleles of the rod and cone Na-Ca+K-exchanger genes in patients with retinal diseases. Invest Ophthalmol Vis Sci (2002) 0.95
Submicrovolt full-field cone electroretinograms: artifacts and reproducibility. Doc Ophthalmol (1998) 0.91
The whole nucleotide sequence and chromosomal localization of the gene for human metabotropic glutamate receptor subtype 6. Eur J Neurosci (1997) 0.90
Cone electroretinograms in congenital nyctalopia with myopia. Am J Ophthalmol (1974) 0.88
Cloning, distribution and functional expression of the human mGlu6 metabotropic glutamate receptor. Neuropharmacology (1997) 0.86
OFF-alpha and OFF-beta ganglion cells in cat retina. I: Intracellular electrophysiology and HRP stains. J Comp Neurol (1993) 0.82
Positive and negative deflections in the off response of the electroretinogram in man. Am J Ophthalmol (1971) 0.79
Temporal aspects of the dark-adapted cone a-wave in retinitis pigmentosa. Invest Ophthalmol Vis Sci (1981) 0.79
Retinitis pigmentosa. Lancet (2006) 13.62
Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc Natl Acad Sci U S A (2008) 7.16
Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol (2011) 3.79
Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A. Arch Ophthalmol (2010) 2.78
Insights from retinitis pigmentosa into the roles of isocitrate dehydrogenases in the Krebs cycle. Nat Genet (2008) 2.58
Defects in RGS9 or its anchor protein R9AP in patients with slow photoreceptor deactivation. Nature (2004) 2.48
The association between visual acuity and central retinal thickness in retinitis pigmentosa. Invest Ophthalmol Vis Sci (2005) 2.40
A comprehensive mutation analysis of RP2 and RPGR in a North American cohort of families with X-linked retinitis pigmentosa. Am J Hum Genet (2002) 2.29
Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol (2006) 2.27
Retinal phenotypes in patients homozygous for the G1961E mutation in the ABCA4 gene. Invest Ophthalmol Vis Sci (2012) 2.26
ω-3 intake and visual acuity in patients with retinitis pigmentosa receiving vitamin A. Arch Ophthalmol (2012) 2.23
Detection of mosaic retinal dysfunction in choroideremia carriers electroretinographic and psychophysical testing. Ophthalmology (2008) 2.14
Association of dark-adapted visual function with retinal structural changes in patients with Stargardt disease. Retina (2014) 1.99
Mutations in NMNAT1 cause Leber congenital amaurosis and identify a new disease pathway for retinal degeneration. Nat Genet (2012) 1.96
Analysis of the ABCA4 gene by next-generation sequencing. Invest Ophthalmol Vis Sci (2011) 1.87
NMNAT1 mutations cause Leber congenital amaurosis. Nat Genet (2012) 1.86
Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome. Arch Ophthalmol (2010) 1.85
RP2 and RPGR mutations and clinical correlations in patients with X-linked retinitis pigmentosa. Am J Hum Genet (2003) 1.83
Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses. Arch Ophthalmol (2004) 1.80
Shared mutations in NR2E3 in enhanced S-cone syndrome, Goldmann-Favre syndrome, and many cases of clumped pigmentary retinal degeneration. Arch Ophthalmol (2003) 1.74
Variation in retinitis pigmentosa-11 (PRPF31 or RP11) gene expression between symptomatic and asymptomatic patients with dominant RP11 mutations. Hum Mutat (2006) 1.71
Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment. Arch Ophthalmol (2004) 1.71
Visual acuity loss and clinical observations in a large series of patients with Stargardt disease. Ophthalmology (2003) 1.69
Photoreceptor structure and function in patients with congenital achromatopsia. Invest Ophthalmol Vis Sci (2011) 1.61
iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration. Hum Mol Genet (2012) 1.59
How strong is the evidence that nutritional supplements slow the progression of retinitis pigmentosa? Arch Ophthalmol (2010) 1.56
Identification of novel mutations in patients with Leber congenital amaurosis and juvenile RP by genome-wide homozygosity mapping with SNP microarrays. Invest Ophthalmol Vis Sci (2007) 1.54
AIPL1, the protein that is defective in Leber congenital amaurosis, is essential for the biosynthesis of retinal rod cGMP phosphodiesterase. Proc Natl Acad Sci U S A (2004) 1.54
Cone cGMP-gated channel mutations and clinical findings in patients with achromatopsia, macular degeneration, and other hereditary cone diseases. Hum Mutat (2005) 1.52
Lack of scientific rationale for use of valproic acid for retinitis pigmentosa. Br J Ophthalmol (2010) 1.52
Comprehensive screening of the USH2A gene in Usher syndrome type II and non-syndromic recessive retinitis pigmentosa. Exp Eye Res (2004) 1.51
ABCA4 gene sequence variations in patients with autosomal recessive cone-rod dystrophy. Arch Ophthalmol (2003) 1.50
Disease progression in patients with dominant retinitis pigmentosa and rhodopsin mutations. Invest Ophthalmol Vis Sci (2002) 1.49
Mutations in RPGR and RP2 account for 15% of males with simplex retinal degenerative disease. Invest Ophthalmol Vis Sci (2012) 1.47
Comprehensive molecular diagnosis of 179 Leber congenital amaurosis and juvenile retinitis pigmentosa patients by targeted next generation sequencing. J Med Genet (2013) 1.47
Gene replacement therapy rescues photoreceptor degeneration in a murine model of Leber congenital amaurosis lacking RPGRIP. Invest Ophthalmol Vis Sci (2005) 1.47
Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis. Arch Ophthalmol (2010) 1.46
Premature termination codons in PRPF31 cause retinitis pigmentosa via haploinsufficiency due to nonsense-mediated mRNA decay. J Clin Invest (2008) 1.45
The prevalence of macular cysts in patients with clinical cone-rod dystrophy determined by spectral-domain optical coherence tomography. Ophthalmic Genet (2013) 1.45
Immunosuppression for autoimmune retinopathy. Arch Ophthalmol (2009) 1.43
Correlation of optical coherence tomography findings with visual acuity and macular lesions in patients with X-linked retinoschisis. Ophthalmology (2005) 1.43
Recessive NRL mutations in patients with clumped pigmentary retinal degeneration and relative preservation of blue cone function. Proc Natl Acad Sci U S A (2004) 1.42
Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations. Invest Ophthalmol Vis Sci (2007) 1.41
Retinal nerve fiber layer analysis in RP patients using Fourier-domain OCT. Invest Ophthalmol Vis Sci (2008) 1.37
Retinal nerve fiber layer defects in RP patients. Invest Ophthalmol Vis Sci (2007) 1.36
Novel mutations in the long isoform of the USH2A gene in patients with Usher syndrome type II or non-syndromic retinitis pigmentosa. J Med Genet (2010) 1.35
Barrier to autointegration factor interacts with the cone-rod homeobox and represses its transactivation function. J Biol Chem (2002) 1.34
Visual acuity in patients with Leber's congenital amaurosis and early childhood-onset retinitis pigmentosa. Ophthalmology (2010) 1.30
Temporal properties of the mouse cone electroretinogram. J Neurophysiol (2002) 1.28
BBS genotype-phenotype assessment of a multiethnic patient cohort calls for a revision of the disease definition. Hum Mutat (2011) 1.28
A homozygous missense mutation in the IRBP gene (RBP3) associated with autosomal recessive retinitis pigmentosa. Invest Ophthalmol Vis Sci (2008) 1.27
Non-exomic and synonymous variants in ABCA4 are an important cause of Stargardt disease. Hum Mol Genet (2013) 1.27
A missense mutation in PRPF6 causes impairment of pre-mRNA splicing and autosomal-dominant retinitis pigmentosa. Am J Hum Genet (2011) 1.26
Autosomal recessive vitelliform macular dystrophy in a large cohort of vitelliform macular dystrophy patients. Retina (2011) 1.24
Differential macular morphology in patients with RPE65-, CEP290-, GUCY2D-, and AIPL1-related Leber congenital amaurosis. Invest Ophthalmol Vis Sci (2009) 1.24
Next generation sequencing of pooled samples reveals new SNRNP200 mutations associated with retinitis pigmentosa. Hum Mutat (2011) 1.23
CERKL mutations cause an autosomal recessive cone-rod dystrophy with inner retinopathy. Invest Ophthalmol Vis Sci (2009) 1.21
A novel mutation (I143NT) in guanylate cyclase-activating protein 1 (GCAP1) associated with autosomal dominant cone degeneration. Invest Ophthalmol Vis Sci (2004) 1.19
Replacement gene therapy with a human RPGRIP1 sequence slows photoreceptor degeneration in a murine model of Leber congenital amaurosis. Hum Gene Ther (2010) 1.19
Evaluation of genotype-phenotype associations in leber congenital amaurosis. Retina (2005) 1.14
Use of dorzolamide for patients with X-linked retinoschisis. Retina (2006) 1.14
Screen of the IMPDH1 gene among patients with dominant retinitis pigmentosa and clinical features associated with the most common mutation, Asp226Asn. Invest Ophthalmol Vis Sci (2005) 1.13
Whole genome sequencing in patients with retinitis pigmentosa reveals pathogenic DNA structural changes and NEK2 as a new disease gene. Proc Natl Acad Sci U S A (2013) 1.13
Comparison of contrast sensitivity, visual acuity, and Humphrey visual field testing in patients with glaucoma. J Glaucoma (2003) 1.12
A single, abbreviated RPGR-ORF15 variant reconstitutes RPGR function in vivo. Invest Ophthalmol Vis Sci (2005) 1.11
Monitoring cystoid macular edema by optical coherence tomography in patients with retinitis pigmentosa. Ophthalmology (2004) 1.10
Natural history of phenotypic changes in Stargardt macular dystrophy. Ophthalmic Genet (2009) 1.10
Variability of full-field electroretinogram responses in subjects without diffuse photoreceptor cell disease. Ophthalmology (2003) 1.10
Improvement in visual function and fundus findings for a patient with vitamin A-deficient retinopathy. Retina (2005) 1.09
Retinal thickness and visual thresholds measured in patients with retinitis pigmentosa. Retina (2007) 1.09
Detection using the multifocal electroretinogram of mosaic retinal dysfunction in carriers of X-linked retinitis pigmentosa. Ophthalmology (2002) 1.09
Optical coherence tomography findings in occult macular dystrophy. Am J Ophthalmol (2006) 1.08
Disease course in patients with autosomal recessive retinitis pigmentosa due to the USH2A gene. Invest Ophthalmol Vis Sci (2008) 1.08
Pharmacological analysis of the rat cone electroretinogram. Vis Neurosci (2003) 1.07
Rebound of cystoid macular edema with continued use of acetazolamide in patients with retinitis pigmentosa. Retina (2007) 1.06
Relation of response to treatment with dorzolamide in X-linked retinoschisis to the mechanism of functional loss in retinoschisin. Am J Ophthalmol (2008) 1.06
The natural history of stargardt disease with specific sequence mutation in the ABCA4 gene. Invest Ophthalmol Vis Sci (2009) 1.06
Absence of photoreceptor rescue with D-cis-diltiazem in the rd mouse. Invest Ophthalmol Vis Sci (2002) 1.06
Discordant phenotypes in fraternal twins having an identical mutation in exon ORF15 of the RPGR gene. Arch Ophthalmol (2008) 1.06
ON-pathway dysfunction and timing properties of the flicker ERG in carriers of X-linked retinitis pigmentosa. Invest Ophthalmol Vis Sci (2003) 1.05
Topical dorzolamide for treatment of cystoid macular edema in patients with choroideremia. Retina (2012) 1.05
Molecular analysis of Bardet-Biedl syndrome families: report of 21 novel mutations in 10 genes. Invest Ophthalmol Vis Sci (2011) 1.05
PRPF mutations are associated with generalized defects in spliceosome formation and pre-mRNA splicing in patients with retinitis pigmentosa. Hum Mol Genet (2011) 1.04
Autoimmune retinopathy and antiretinal antibodies: a review. Retina (2014) 1.04